Chemical Name: α-[(2-(3-Chlorophenyl)hydrazinylidene]-5-(1,1-dimethylethyl)-β-oxo-3-isoxazolepropanenitrile
Biological ActivityESI 09 is an EPAC inhibitor. Inhibits EPAC-mediated insulin release from pancreatic β cells. Selective for EPAC over PKA. ESI 09 decreases migration and invasion of AsPc-1 and PANC-1 pancreatic cancer cells in vitro.
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
A novel EPAC-specific inhibitor suppresses pancreatic cancer cell migration and invasion.
Almahariq et al.
Citations for ESI 09
The citations listed below are publications that use Tocris products. Selected citations for ESI 09 include:
4 Citations: Showing 1 - 4
Autocrine-paracrine prostaglandin E2 signaling restricts TLR4 internalization and TRIF signaling.
Authors: Perkins Et al.
Exchange Protein Directly Activated by cAMP Modulates Ebola Virus Uptake into Vascular Endothelial Cells.
Authors: Drelich Et al.
Anthrax edema toxin disrupts distinct steps in Rab11-dependent junctional transport.
Authors: Guichard Et al.
PLoS Pathog 2017;13:e1006603
A pivotal role of FOS-mediated BECN1/Beclin 1 upregulation in DA D2 and D3 receptor agonist-induced autophagy activation.
Authors: Wang Et al.
EMBO Mol Med 2015;11:2057
No product specific FAQs exist for this product, however you mayView all Small Molecule FAQs
Reviews for ESI 09
There are currently no reviews for this product. Be the first to review ESI 09 and earn rewards!
Have you used ESI 09?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image